The Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s (FDA) move to institutionalize a “Green Lane” that will fast-track regulatory processes for health establishments and products aligned with national development priorities.
The Philippines’ drive for medicine security is gaining momentum as Congress, regulatory agencies, and industry leaders move to reduce the country’s dependence on imported drugs through tighter coordination and new policy reforms.
The program aims to assist entrepreneurs in securing their License to Operate (LTO) and Certificate of Product Registration (CPR) from the Philippine Food and Drug Administration (FDA).